Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BDMD NASDAQ:PDEX NASDAQ:SMTI NASDAQ:STEX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBDMDBaird Medical Investment$1.80-1.4%$2.09$0.76▼$7.26$73.56M-1.181.57 million shs85,433 shsPDEXPro-Dex$56.55+1.0%$48.97$23.47▼$57.17$180.37M-0.1225,891 shs6,648 shsSMTISanara MedTech$19.73+0.6%$18.87$16.05▼$35.95$180.73M1.1658,718 shs15,259 shsSTEXBiosig Technologies$0.96+4.6%$1.47$0.70▼$14.11$173.71M1.581.93 million shs581,750 shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBDMDBaird Medical Investment+1.68%+8.33%-6.67%+85.22%-66.67%PDEXPro-Dex+15.80%+8.72%+8.38%+42.49%+24.61%SMTISanara MedTech-0.56%+4.92%+13.81%-5.13%-39.37%STEXBiosig Technologies-22.20%+2.68%-20.86%-70.67%+91,799,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBDMDBaird Medical Investment$1.80-1.4%$2.09$0.76▼$7.26$73.56M-1.181.57 million shs85,433 shsPDEXPro-Dex$56.55+1.0%$48.97$23.47▼$57.17$180.37M-0.1225,891 shs6,648 shsSMTISanara MedTech$19.73+0.6%$18.87$16.05▼$35.95$180.73M1.1658,718 shs15,259 shsSTEXBiosig Technologies$0.96+4.6%$1.47$0.70▼$14.11$173.71M1.581.93 million shs581,750 shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBDMDBaird Medical Investment+1.68%+8.33%-6.67%+85.22%-66.67%PDEXPro-Dex+15.80%+8.72%+8.38%+42.49%+24.61%SMTISanara MedTech-0.56%+4.92%+13.81%-5.13%-39.37%STEXBiosig Technologies-22.20%+2.68%-20.86%-70.67%+91,799,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBDMDBaird Medical Investment 1.00SellN/AN/APDEXPro-Dex 2.50Moderate Buy$56.00-0.97% DownsideSMTISanara MedTech 2.25Hold$34.0072.33% UpsideSTEXBiosig Technologies 2.00Hold$9.00837.50% UpsideCurrent Analyst Ratings BreakdownLatest BDMD, SMTI, PDEX, and STEX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/1/2026PDEXPro-Dex Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C+)5/1/2026STEXBiosig Technologies Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/24/2026BDMDBaird Medical Investment Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)4/21/2026SMTISanara MedTech Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/15/2026SMTISanara MedTech Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$32.004/9/2026STEXBiosig Technologies Needham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$12.00 ➝ $9.00(Data available from 5/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBDMDBaird Medical Investment$22.54M3.26N/AN/AN/A∞PDEXPro-Dex$66.59M2.71$3.46 per share16.34$14.16 per share3.99SMTISanara MedTech$103.12M1.75$0.62 per share31.94$0.67 per share29.45STEXBiosig Technologies$40K4,347.36N/AN/A$0.83 per share1.16Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBDMDBaird Medical InvestmentN/AN/AN/AN/AN/AN/AN/AN/AN/APDEXPro-Dex$8.98M$3.6215.62N/AN/A16.08%22.78%14.30%7/8/2026 (Estimated)SMTISanara MedTech-$37.56M-$4.23N/AN/AN/A-36.42%-20.73%-5.14%5/12/2026 (Estimated)STEXBiosig Technologies-$462.77M-$9.58N/AN/AN/AN/A-1,476.78%-428.30%N/ALatest BDMD, SMTI, PDEX, and STEX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026Q1 2026SMTISanara MedTech-$0.13N/AN/AN/A$26.80 millionN/A4/30/2026Q3 2026PDEXPro-Dex$0.62$1.20+$0.58$1.20$17.90 million$19.95 million3/31/2026Q4 2025STEXBiosig TechnologiesN/A-$8.23N/A-$8.23N/AN/A3/24/2026Q4 2025SMTISanara MedTech$0.11$0.04-$0.07-$0.19$27.90 million$27.55 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBDMDBaird Medical InvestmentN/AN/AN/AN/AN/APDEXPro-DexN/AN/AN/AN/AN/ASMTISanara MedTechN/AN/AN/AN/AN/ASTEXBiosig TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBDMDBaird Medical InvestmentN/AN/AN/APDEXPro-Dex0.323.672.25SMTISanara MedTech7.751.801.59STEXBiosig TechnologiesN/A1.681.68Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBDMDBaird Medical Investment19.78%PDEXPro-Dex15.28%SMTISanara MedTech8.10%STEXBiosig Technologies7.16%Insider OwnershipCompanyInsider OwnershipBDMDBaird Medical Investment78.90%PDEXPro-Dex45.90%SMTISanara MedTech42.00%STEXBiosig Technologies52.73%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBDMDBaird Medical InvestmentN/A40.98 million8.65 millionN/APDEXPro-Dex1403.19 million1.73 millionNot OptionableSMTISanara MedTech609.16 million5.32 millionNot OptionableSTEXBiosig Technologies50181.14 million85.63 millionN/ABDMD, SMTI, PDEX, and STEX HeadlinesRecent News About These CompaniesBiosig Technologies (NASDAQ:STEX) CIO Sells $208,451.77 in StockMay 5 at 4:52 AM | insidertrades.comBiosig Technologies (NASDAQ:STEX) CIO Mitchell Young Williams Sells 263,863 SharesMay 4 at 7:06 PM | marketbeat.comBiosig Technologies (NASDAQ:STEX) & Check-Cap (NASDAQ:MBAI) Head-To-Head ReviewMay 2, 2026 | americanbankingnews.comStreamex Corp. Announces First Yield Dividend Distribution for GLDYApril 28, 2026 | globenewswire.comBiosig Technologies (NASDAQ:STEX) CFO Christine Marie Plummer Sells 10,922 SharesApril 18, 2026 | insidertrades.comChristine Marie Plummer Sells 10,922 Shares of Biosig Technologies (NASDAQ:STEX) StockApril 17, 2026 | marketbeat.comInsider Selling: Biosig Technologies (NASDAQ:STEX) Chairman Sells 12,759 Shares of StockApril 17, 2026 | marketbeat.comKarl Henry Michael Mcphie Sells 30,611 Shares of Biosig Technologies (NASDAQ:STEX) StockApril 17, 2026 | marketbeat.comBiosig Technologies (NASDAQ:STEX) Price Target Cut to $9.00 by Analysts at Needham & Company LLCApril 9, 2026 | marketbeat.comStreamex Corp. (STEX) Q4 2025 Earnings Call TranscriptApril 8, 2026 | seekingalpha.comStreamex Corp. Announces Webcast Details for Wednesday, April 8 Earnings and Corporate Update PresentationApril 6, 2026 | globenewswire.comStreamex Corp. Highlights Year of Progress, Files Annual Report & Announces Earnings and Corporate Update PresentationApril 1, 2026 | markets.businessinsider.comStreamex Corp. Clarifies and Refutes Inaccurate Claims Regarding Lock-Up Agreements; Co-Founders Morgan Lekstrom & Henry McPhie Enter into Voluntary 1 Year Lock-Up AgreementsMarch 27, 2026 | globenewswire.comStreamex Corp.March 27, 2026 | barrons.comStreamex Corp. to Present at the 38th Annual ROTH ConferenceMarch 19, 2026 | globenewswire.comStreamex Corp. Appoints Christine Plummer, Former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial OfficerMarch 16, 2026 | globenewswire.comMorgan Lee Lekstrom Acquires 20,000 Shares of Biosig Technologies (NASDAQ:STEX) StockFebruary 19, 2026 | insidertrades.comStreamex Corp. (NASDAQ: STEX) Co-Founder & Executive Chairman Provides Corporate UpdateFebruary 10, 2026 | globenewswire.comStreamex Corp. (NASDAQ: STEX) Appoints Anthony Marciano, Clinical Professor of Finance at NYU Stern to Board of DirectorsFebruary 5, 2026 | markets.businessinsider.comInsider Buying: Biosig Technologies (NASDAQ:STEX) Major Shareholder Acquires 100,000 Shares of StockFebruary 5, 2026 | insidertrades.comInsider Buying: Biosig Technologies (NASDAQ:STEX) Director Purchases 5,500 Shares of StockJanuary 28, 2026 | insidertrades.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBDMD, SMTI, PDEX, and STEX Company DescriptionsBaird Medical Investment NASDAQ:BDMD$1.80 -0.03 (-1.37%) As of 12:01 PM Eastern This is a fair market value price provided by Massive. Learn more.Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.Pro-Dex NASDAQ:PDEX$56.55 +0.55 (+0.98%) As of 12:00 PM Eastern This is a fair market value price provided by Massive. Learn more.Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.Sanara MedTech NASDAQ:SMTI$19.73 +0.11 (+0.56%) As of 12:00 PM Eastern This is a fair market value price provided by Massive. Learn more.Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.Biosig Technologies NASDAQ:STEX$0.96 +0.04 (+4.58%) As of 12:00 PM Eastern This is a fair market value price provided by Massive. Learn more.BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Just How Big a Problem Could Amazon’s Cash Burn Rate Be? BlackBerry Rewrites Its Own Operating System Grab Holdings Faces Hurdles, But Upside Potential Is Hard to Ignore Palantir Drops After a Blowout Q1—What Investors Should Know Shopify’s Valuation Crisis Creates Opportunity in 2026 onsemi Stock Dips After Earnings: Why the Dip Is Buyable TSLA: 3 Reasons the Stock Could Hit $400 in May Nebius Breaks Out to All-Time Highs—Here's What's Driving It. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
